Klinikum Garmisch-Partenkirchen Gmbh
Garmisch Partenkirchen, Germany
General hospital in Garmisch-Partenkirchen, Bavaria
Auenstraße 6, 82467 Garmisch-Partenkirchen
About Klinikum Garmisch-Partenkirchen Gmbh
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German CLL Study Group
6
Deutsches Herzzentrum Muenchen
3
Celgene
2
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
DePuy International
1
DePuy Orthopaedics
1
EndoStim Inc.
1
Hoffmann-La Roche
1
III. Medizinische Klinik Mannheim
1
Institut für Klinisch-Kardiovaskuläre Forschung GmbH
1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
1
Clinical Trials at Klinikum Garmisch-Partenkirchen Gmbh
During the past decade, Klinikum Garmisch-Partenkirchen Gmbh conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)
2003-06-01
2008-03-01
Completed
800
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
2005-11-01
2011-03-01
Completed
195
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
2005-10-01
2015-06-01
Completed
825
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
1999-07-01
2007-07-01
Completed
375
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
2002-09-01
2009-12-01
Completed
17
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Garmisch-Partenkirchen Gmbh" #1 sponsor was "German CLL Study Group" with 6 trials, followed by "Deutsches Herzzentrum Muenchen" with 3 trials
sponsored, "Celgene" with 2 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored and "DePuy International"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Garmisch-Partenkirchen Gmbh"
#1 collaborator was "Technical University of Munich" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BMBf (Federal Ministry of Education and Research)" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Klinikum Garmisch-Partenkirchen Gmbh
According to Clinical.Site data, the most researched conditions in "Klinikum Garmisch-Partenkirchen Gmbh" are
"Chronic Lymphocytic Leukemia" (5 trials), "Coronary Artery Disease" (2 trials), "Eosinophilic Esophagitis" (2 trials), "Leukemia" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Klinikum Garmisch-Partenkirchen Gmbh" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Garmisch-Partenkirchen Gmbh
Most popular intervention types in "Klinikum Garmisch-Partenkirchen Gmbh" are "Drug" (17 trials), "Biological" (6 trials), "Device" (4 trials), "Other" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Fludarabine" (4 trials), "cyclophosphamide" (4 trials), "Rituximab" (3 trials), "radiation therapy" (3 trials) and "CC-93538" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Garmisch-Partenkirchen Gmbh
The vast majority of trials in "Klinikum Garmisch-Partenkirchen Gmbh" are
22 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Klinikum Garmisch-Partenkirchen Gmbh
Currently, there are NaN active trials in "Klinikum Garmisch-Partenkirchen Gmbh".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Klinikum Garmisch-Partenkirchen Gmbh,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Garmisch-Partenkirchen Gmbh, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 1 trials that are defined as “Not Applicable".